<?xml version="1.0" encoding="UTF-8"?>
<p>Franklyne, in a review, presents the potential of EO as a drug delivery vehicle for water insoluble drugs and drugs with low intestinal absorption [
 <xref rid="B39-pharmaceutics-13-00631" ref-type="bibr">39</xref>]. The mechanism of the antimicrobial actions of EOs, which cause damage to the bacterial cell wall or cell membranes, inducing complete cell disorganization and disruption, is also mentioned. Moreover, it is also highlighted that the presence of peripheral cytoplasmic condensations [
 <xref rid="B40-pharmaceutics-13-00631" ref-type="bibr">40</xref>], irreversible loss of viability [
 <xref rid="B41-pharmaceutics-13-00631" ref-type="bibr">41</xref>], increase in cell membrane permeability [
 <xref rid="B42-pharmaceutics-13-00631" ref-type="bibr">42</xref>], and partial solubilization of the cell membrane by fatty acids, leads to the release of membrane proteins and uncoupling of oxidative phosphorylation, or enzyme and nutrient uptake inhibition; thus, causing bacteriostasis [
 <xref rid="B43-pharmaceutics-13-00631" ref-type="bibr">43</xref>].
</p>
